Pilan Capital is poised for growth in China's recovering venture capital market, focusing on innovative healthcare and technology sectors while preparing for significant IPO exits.

Information on the Target

Pilan Capital is a well-established venture capital firm that has successfully navigated through two investment cycles, refining its unique business strategy comprising fundraising, investment, management, and exit avenues. The firm has developed standardized processes and management practices, allowing it to efficiently manage both the front-end investment operations and back-end support functions.

In 2025, Pilan Capital is actively engaging in several projects, with three of its portfolio companies having submitted IPO applications in the second quarter. As the capital market shows signs of recovery, the firm anticipates that its early-stage investments will start to yield returns.

Industry Overview in China

The venture capital industry in China is experiencing a notable resurgence in 2025 following a significant adjustment in the policy and market landscape in 2024. Data indicates that investments in hard tec

View Source

Similar Deals

新宜资本 深轻科技

2023

Other VC Property & Casualty Insurance (NEC) China
Eiffel Investment Group and Mirova OpenAirlines

2025

Other VC Mutual Funds (NEC) France
Kinnevik Nory

2025

Other VC Investment Holding Companies (NEC) Sweden
蔚来资本 主线科技

2025

Other VC Freight Trucking China
蔚来资本 海德氢能

2025

Other VC Hydrogen Fuel China

磐霖资本

invested in

丹擎医药

in 2025

in a Other VC deal

Disclosed details

Transaction Size: $217M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert